Liver Transplant Recipients
📧 Sign up to get email alerts when something new happens for Liver Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Peer Support for Liver Transplant Recipients With History of ALD [NA]
A Johns Hopkins University trial is investigating peer support for liver transplant recipients with a history of alcohol-related liver disea…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
Completed clinical trial evaluating long-haul COVID-19 and vaccine immunogenicity in patients with liver disease.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Envarsus XL Immunosuppression Following Liver Transplantation [Phase 2]
Phase 2 clinical trial update on Envarsus XL for immunosuppression after liver transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients [Phase 2]
Phase 2 trial update on immunosuppression withdrawal in stable pediatric liver transplant recipients; results posted in 2017.
-
FDA label_change · 2015-11-13FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis, resulting in changes to the product labeling. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients [Phase 3]
Phase 3 trial comparing maribavir to oral ganciclovir for CMV disease prevention in liver transplant recipients has completed with results p…